Abbott agrees to divest two medical device businesses

Healthcare company Abbott Laboratories has agreed to divest two medical device businesses in a bid to settle competition charges brought by the US Federal Trade Commission (FTC).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

5 November 2020 Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.

Americas

Abbott unit prevails in dispute over catheter patent

25 March 2021 In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

More on this story

Americas

Abbott unit prevails in dispute over catheter patent

25 March 2021 In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

More on this story

Americas

Abbott unit prevails in dispute over catheter patent

25 March 2021 In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute